Literature DB >> 19756893

Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus.

Federico Soriguer1, Lourdes Garrido-Sanchez, Sara Garcia-Serrano, Jose M Garcia-Almeida, Juan Garcia-Arnes, Francisco J Tinahones, Eduardo Garcia-Fuentes.   

Abstract

BACKGROUND: The physiological role of apelin in obesity and diabetes remains unclear. Although apelin has been studied in persons with different conditions, no studies have yet examined the joint influence of obesity and diabetes on apelin levels. We measured the changes in apelin levels in morbidly obese subjects, with and without diabetes, and in the inverse situation of improvement in carbohydrate metabolism as a result of bariatric surgery.
METHODS: The study was undertaken in 54 morbidly obese persons, 16 of whom had type 2 diabetes mellitus, before and 7 months after undergoing bariatric surgery, and in 12 healthy, nonobese persons. Measurements were made of apelin levels and insulin sensitivity by an intravenous glucose tolerance test.
RESULTS: The apelin levels in the morbidly obese patients prior to surgery were significantly higher than those of the controls only when the morbidly obese subjects were diabetic (P < 0.005). Apelin levels correlated significantly in the morbidly obese patients with serum triglycerides (r = 0.292, P = 0.032) and glucose (r = 0.337, P = 0.039). Bariatric surgery resulted in a significant decrease in apelin levels only in the morbidly obese subjects with impaired fasting glucose or diabetes. The change in apelin levels correlated significantly in the morbidly obese patients with the changes in serum glucose (r = 0.338, P = 0.038) and insulin sensitivity (r = -0.417, P = 0.043).
CONCLUSIONS: This study demonstrates that obesity is not the main determinant of the rise in apelin levels. The association between apelin levels and glucose concentrations and insulin sensitivity provides evidence that apelin may play a role in the pathogenesis of diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756893     DOI: 10.1007/s11695-009-9955-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  26 in total

1.  Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes.

Authors:  Li Wei; Xinghua Hou; Kazuhiko Tatemoto
Journal:  Regul Pept       Date:  2005-08-31

2.  The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice.

Authors:  Maria Sörhede Winzell; Caroline Magnusson; Bo Ahrén
Journal:  Regul Pept       Date:  2005-11

3.  Apelin, a newly identified adipokine up-regulated by insulin and obesity.

Authors:  Jérémie Boucher; Bernard Masri; Danièle Daviaud; Stéphane Gesta; Charlotte Guigné; Anne Mazzucotelli; Isabelle Castan-Laurell; Ivan Tack; Bernard Knibiehler; Christian Carpéné; Yves Audigier; Jean-Sébastien Saulnier-Blache; Philippe Valet
Journal:  Endocrinology       Date:  2005-01-27       Impact factor: 4.736

Review 4.  Apelin signalling: a promising pathway from cloning to pharmacology.

Authors:  B Masri; B Knibiehler; Y Audigier
Journal:  Cell Signal       Date:  2005-04       Impact factor: 4.315

5.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.

Authors:  K Tatemoto; M Hosoya; Y Habata; R Fujii; T Kakegawa; M X Zou; Y Kawamata; S Fukusumi; S Hinuma; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

Review 6.  A putative role for apelin in the etiology of obesity.

Authors:  Srujana Rayalam; Mary Anne Della-Fera; Paul A Krieg; Christopher M Cox; Allan Robins; Clifton A Baile
Journal:  Biochem Biophys Res Commun       Date:  2008-02-12       Impact factor: 3.575

7.  Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass.

Authors:  Eduardo García-Fuentes; Jose M García-Almeida; Juan García-Arnés; Sara García-Serrano; Jose Rivas-Marín; Jose L Gallego-Perales; Gemma Rojo-Martínez; Lourdes Garrido-Sánchez; Francisco J Bermudez-Silva; Fernando Rodríguez de Fonseca; Federico Soriguer
Journal:  Obesity (Silver Spring)       Date:  2007-10       Impact factor: 5.002

8.  Apelin expression in normal human tissues.

Authors:  Maria De Falco; Luca De Luca; Nicoletta Onori; Ivan Cavallotti; Francesca Artigiano; Vincenzo Esposito; Bruno De Luca; Vincenza Laforgia; Angela M Groeger; Antonio De Luca
Journal:  In Vivo       Date:  2002 Sep-Oct       Impact factor: 2.155

Review 9.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach.

Authors:  R N Bergman
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

10.  Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.

Authors:  Xing Cheng; Xiao Shuo Cheng; Catherine C Y Pang
Journal:  Eur J Pharmacol       Date:  2003-06-06       Impact factor: 4.432

View more
  40 in total

Review 1.  Apelin and insulin resistance: another arrow for the quiver?

Authors:  Shiming Xu; Philip S Tsao; Patrick Yue
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

2.  Apelin Reduces Nitric Oxide-Induced Relaxation of Cerebral Arteries by Inhibiting Activation of Large-Conductance, Calcium-Activated K Channels.

Authors:  Amreen Mughal; Chengwen Sun; Stephen T OʼRourke
Journal:  J Cardiovasc Pharmacol       Date:  2018-04       Impact factor: 3.105

Review 3.  Adipose tissue and vascular inflammation in coronary artery disease.

Authors:  Enrica Golia; Giuseppe Limongelli; Francesco Natale; Fabio Fimiani; Valeria Maddaloni; Pina Elvira Russo; Lucia Riegler; Renatomaria Bianchi; Mario Crisci; Gaetano Di Palma; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò; Paolo Calabrò
Journal:  World J Cardiol       Date:  2014-07-26

4.  Apelin is a novel regulator of human trophoblast amino acid transport.

Authors:  O R Vaughan; T L Powell; T Jansson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-05       Impact factor: 4.310

Review 5.  Apelin, diabetes, and obesity.

Authors:  Isabelle Castan-Laurell; Cédric Dray; Camille Attané; Thibaut Duparc; Claude Knauf; Philippe Valet
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

6.  Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus.

Authors:  Mehmet Aslan; Onder Celik; Nilufer Celik; Ilgin Turkcuoglu; Ercan Yilmaz; Abdullah Karaer; Yavuz Simsek; Ebru Celik; Suleyman Aydin
Journal:  Endocrine       Date:  2011-12-28       Impact factor: 3.633

Review 7.  Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss.

Authors:  Gian Franco Adami; Nicola Scopinaro; Renzo Cordera
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

8.  Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity.

Authors:  Sarah-Maude Caron-Cantin; Julie Martin; Marjorie Bastien; Mercedes Nancy Munkonda; Huiling Lu; Katherine Cianflone; Fady Moustarah; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Jean Bussières; Paul Poirier
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

9.  Increased bone mass in mice lacking the adipokine apelin.

Authors:  Lalita Wattanachanya; Wei-Dar Lu; Ramendra K Kundu; Liping Wang; Marcia J Abbott; Dylan O'Carroll; Thomas Quertermous; Robert A Nissenson
Journal:  Endocrinology       Date:  2013-04-12       Impact factor: 4.736

10.  Apelin attenuates oxidative stress in human adipocytes.

Authors:  Aung Than; Xiaohong Zhang; Melvin Khee-Shing Leow; Chueh Loo Poh; Seow Khoon Chong; Peng Chen
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.